Publications by authors named "Hamada Hashem"

Claim this Profile
D
Design, Synthesis, and Mechanistic Study of Novel Ciprofloxacin/Thiazole Chalcone Hybrids as Potential Anticancer Agents.
Hamada Hashem, Ali M Elshamsy, Safwat M Rabea, Adel A Marzouk, Stefan Bräse

Pharmaceuticals (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical delivery of meropenem via spanlastic carbopol gel: studies and application in pressure ulcers.
Shadwa Abdelfattah, Fatma Mohamed Mady, Hatem A Sarhan, Hazim O Khalifa, Hamada Hashem

Front Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current progress of 1,2,3-triazole hybrids as EGFR inhibitors for cancer therapy - a literature review.
Hussam Elddin Nabeih Khasawneh, Hesham M Hassan, Amal Ali Alharbi, Wesam Taher Almagharbeh, Raed Fanoukh Aboqader Al-Aouadi, Hamada Hashem

RSC Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silver nanoparticles as next-generation antimicrobial agents: mechanisms, challenges, and innovations against multidrug-resistant bacteria.
Hazim O Khalifa, Atef Oreiby, Temesgen Mohammed, Mohamed A A Abdelhamid, Essam Nageh Sholkamy, Hamada Hashem

Front Cell Infect Microbiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and In Vitro Anticancer Evaluation of Thiazole-Based Chalcones Linked to Sulfanilamide as Tumor-Associated Carbonic Anhydrase IX and XII Inhibitors.
Ali M Elshamsy, Muhamad Mustafa, Alessio Nocentini, Maria Luisa Massardi, Taha F S Ali, Hamada Hashem

J Med Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the perioperative, postoperative, and oncological outcomes between robotic and transanal total mesorectal excision for rectal cancer: an updated systematic review and meta-analysis of prospective studies with a subgroup analysis for overweight patients.
Konstantinos Kossenas, Riad Kouzeiha, Hamada Hashem, Ali Elshamsy, Filippos Georgopoulos

J Robot Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel 4-pyridyl SLC-0111 analog targeting tumor-associated carbonic anhydrase isoform IX through tail-based design approach with potent anticancer activity.
Hamada Hashem, Shadwa Abdelfattah, Hesham M Hassan, Ahmed Al-Emam, Mohammed Alqarni

Front Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and in-Silco ADME prediction of some novel bis(1,3,4-thiadiazoles) encapsulated lipid-chitosan nano capsule decorative with magnetic nanoparticles and their potential anti-helicobacter pylori activity.
Mostafa E Salem, Ahmed H M Elwahy, Hamdi M Hassaneen, Abdelfattah M Selim, Hamada Hashem

Int J Biol Macromol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assessment of the synergistic effects of cefotaxime, colistin, and fosfomycin combinations against foodborne resistant Escherichia coli and Salmonella isolates.
Hazim O Khalifa, Temesgen Mohammed, Mohamed-Yousif Ibrahim Mohamed, Hamada Hashem, Ihab Habib

J Antibiot (Tokyo)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, Anticancer Screening, and Mechanistic Study of Spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide Derivatives.
Ahmed M El-Saghier, Hamada Hashem, Sherif A Maher, Souhaila S Enaili, Abdullah Alkhammash

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents.
Hesham M Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, Ahmed Al-Emam, Konstantinos Kossenas, Hamada Hashem

Pharmaceuticals (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer.
Doaa Mohamed Elroby Ali, Hossameldin A Aziz, Stefan Bräse, Areej Al Bahir, Abdullah Alkhammash, Hamada Hashem

Molecules· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery-An Updated Review on Their Multifaceted Therapeutic Applications (2020-2024).
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, Roket Hassan, Ahmed S Abdel-Samea, Hamada Hashem

Molecules· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities.
Hamada Hashem, Abdelfattah Hassan, Walid M Abdelmagid, Ahmed G K Habib, Mohamed A A Abdel-Aal

Pharmaceuticals (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis